Ian Bolland is joined by Jonathan O’Halloran, chief executive officer of QuantuMDx, to discuss the uses of PCR testing (aside from COVID), its latest technology, the difference between point of need and point of care testing, the UK government policy on diagnostics and where the industry stands in light of the pandemic.